Related Experiment Video
Updated: May 2, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Fungal infection in patients with Alzheimer's disease
Ruth Alonso1, Diana Pisa1, Ana Isabel Marina1
1Centro de Biología Molecular Severo Ochoa CSIC-UAM, C/ Nicolás Cabrera, 1 Universidad Autónoma de Madrid, Cantoblanco, Madrid, Spain.
Abstract:
Alzheimer's disease is a progressive neurodegenerative disorder that leads to dementia mainly among the elderly. This disease is characterized by the presence in the brain of amyloid plaques and neurofibrillary tangles that provoke neuronal cell death, vascular dysfunction, and inflammatory processes. In the present work, we have analyzed the existence of fungal infection in Alzheimer's disease patients. A proteomic analysis provides compelling evidence for the existence of fungal proteins in brain samples from Alzheimer's disease patients. Furthermore, PCR analysis reveals a variety of fungal species in these samples, dependent on the patient and the tissue tested. DNA sequencing demonstrated that several fungal species can be found in brain samples. Together, these results show that fungal macromolecules can be detected in brain from Alzheimer's disease patients. To our knowledge these findings represent the first evidence that fungal infection is detectable in brain samples from Alzheimer's disease patients. The possibility that this may represent a risk factor or may contribute to the etiological cause of Alzheimer's disease is discussed.
Insights
This study found fungal proteins and DNA in Alzheimer's disease (AD) brains, suggesting a potential fungal infection link to AD. Further research is needed to explore if fungi are a risk factor or cause of this neurodegenerative disease.
Area of Science:
- Neuroscience
- Mycology
- Pathology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing dementia, characterized by amyloid plaques and neurofibrillary tangles.
- Current understanding of AD etiology is incomplete, with research exploring various contributing factors beyond genetics and aging.
Purpose of the Study:
- To investigate the presence and detectability of fungal infection in brain samples from Alzheimer's disease patients.
- To identify fungal species and macromolecules within the brain tissue of individuals with AD.
Main Methods:
- Proteomic analysis was employed to detect fungal proteins in AD brain samples.
- Polymerase Chain Reaction (PCR) and DNA sequencing were used to identify fungal species present in the brain tissue.
Main Results:
- Compelling evidence of fungal proteins was found in brain samples from Alzheimer's disease patients.
- PCR and DNA sequencing identified a variety of fungal species in the brain samples, with variations depending on the patient and tissue.
- Fungal macromolecules were demonstrably detected in brain tissue from AD patients.
Conclusions:
- These findings represent the first evidence of detectable fungal infection in brain samples from Alzheimer's disease patients.
- The study discusses the potential role of fungal infection as a risk factor or contributing etiological cause of Alzheimer's disease.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Treatment
Dementia l: Introduction
Fungal Phylum Microsporidia

